| Net loss | -2.34M |
| Depreciation and amortization | 21.59K |
| Accretion of preferred stock redemption value | |
| Stock-based compensation expense | 525.89K |
| Grant funds receivable | 111.21K |
| Prepaid expenses and other current assets | -25.65K |
| Deposits and other assets | |
| Accounts payable and accrued expenses | 125.6K |
| Total adjustments | 758.64K |
| Net cash used in operating activities | |
| Purchase of property and equipment | 0 |
| Proceeds from sale of property and equipment | |
| Net cash used in investing activities | |
| Net proceeds from sale of common stock | 1.03M |
| Net proceeds from sale of preferred stock | 0 |
| Costs associated with planned stock offering | |
| Net cash provided (used) by financing activities | |
| Net increase (decrease) in cash and cash equivalents | -549.25K |
| Cash and cash equivalents at beginning of period | 1.06M |
| Cash and cash equivalents at end of period | 511.1K |
| Interest paid | |